Donation Treatment Frequently Asked Questions

An umbrella term for assisted reproduction treatments in which eggs, sperm or both gametes are provided by an appropriately screened donor.

In egg donation only the eggs are donated; in sperm donation only the sperm is donated; in the use of the term embryo donation on this page, both the egg and sperm come from donors.

It may be considered, subject to medical and legal suitability, when the chance of pregnancy using a person’s own gametes is very low, when gametes cannot be obtained, or when certain inherited risks are present.

No. Donor gametes may reduce some egg- or sperm-related barriers, but fertilisation, embryo development, pregnancy and live birth cannot be guaranteed.

Screening and laboratory safeguards aim to reduce known risks; no programme can guarantee a healthy child.

The genetic relationship depends on the sources of the egg and sperm. The person carrying the pregnancy has a genetic relationship only if their own egg is used.

It can be helpful when considering genetic relationships, privacy, disclosure to the child and communication within the family; some programmes particularly recommend it.

Before gametes or embryos are used, changes may be possible depending on consent requirements. Once fertilisation, transfer or storage has begun, the legal implications of decisions may differ.

Medical and family history, physical assessment, infectious-disease testing and programme-appropriate genetic carrier screening may be considered.

No. No panel covers every genetic risk, and a negative result does not mean zero risk.

When appropriate carrier-screening results are available, the risk of both parties carrying the same recessive condition can be assessed.

It may be considered during matching, but it does not by itself determine medical suitability or treatment success.

Basic characteristics may be considered to the extent permitted by applicable rules. An exact resemblance or a child’s appearance cannot be guaranteed.

Anonymity and future access to identifying information vary according to national law; patients should receive a written explanation before treatment.

This depends on local regulations and programme policy. Personal information that cannot legally be disclosed must not be shown.

High-quality programmes use unique identification, independent checks and electronic witnessing to reduce this risk. The process still requires regular quality oversight.

It may create risks relating to incomplete infection and genetic screening, sample traceability, legal parenthood and future communication.

No. The aim is not to find perfect characteristics, but to select a donor who meets safety criteria and is clinically appropriate.

Donor eggs are fertilised with sperm, and a suitably developing embryo is transferred into the prepared uterus.

It may be considered in situations such as premature ovarian insufficiency, severely reduced ovarian reserve, repeated poor oocyte quality or certain genetic risks.

Usually not. The recipient’s main medical steps are endometrial preparation and embryo transfer.

In a fresh programme, donor stimulation takes place during the same treatment period; in a frozen programme, previously cryopreserved eggs are warmed for use.

No. Conventional IVF or ICSI may be selected according to sperm characteristics and the laboratory plan.

After donor selection and investigations, endometrial preparation and embryo creation are commonly planned within a schedule of several weeks.

Donor egg factors, sperm characteristics, embryo development, uterine conditions, embryo transfer and laboratory quality all play a role.

Embryos of suitable development may be vitrified and stored in accordance with consent and storage requirements.

Donor sperm may be placed into the uterus for IUI in suitable patients, or used to fertilise eggs through IVF or ICSI.

It may be considered in severe male-factor infertility where sperm cannot be obtained, certain risks of transmitting a genetic condition, or other appropriate family-building circumstances.

The decision depends on factors including female age, ovarian reserve, tubal status, previous treatment and any additional causes of infertility.

Most programmes use frozen samples after screening and documentation have been completed; practice may vary by country and sperm bank.

Motility can change after thawing. The laboratory assesses the sample and prepares it appropriately for the planned treatment.

Not always. The method is selected according to the donor sample, number of eggs and any previous fertilisation history.

It can involve important risks relating to medical screening, infection control, sample safety and legal rights.

Important factors include egg age, tubal status, uterine conditions, the treatment method used and general health.

On this page, the term refers to double donation in which new embryos are created using donor eggs and donor sperm.

No. In some countries that is also called embryo donation; the embryo has already been created and the legal pathway may be different.

It may be considered when neither egg nor sperm can be used, when there is significant inherited risk on both sides, or in other appropriate circumstances.

Yes. The health and genetic assessments of the egg donor and sperm donor are performed separately and the results are considered together.

If the recipient uses neither their own egg nor sperm, there is no genetic relationship through the embryo; there is, however, the relationship of carrying the pregnancy.

It may be possible when the uterus and embryo development are suitable; a frozen transfer may also be planned for clinical or logistical reasons.

It may reduce some barriers related to the gamete sources, but it does not guarantee a live birth.

Depending on consent and applicable regulations, they may be frozen and stored or managed according to other permitted decisions.

An IUI programme may be completed within one cycle; IVF and egg or embryo donation are commonly carried out over a schedule of several weeks.

It varies according to treatment type, where monitoring is performed, and the timing of egg collection, sperm provision and embryo transfer.

Many routine investigations can be completed where you live; the clinic should confirm that the results are appropriate in terms of date and testing method.

For the recipient, endometrial preparation and embryo transfer are usually relatively minor steps. In programmes where the recipient does not undergo egg collection, a surgical procedure may not be required.

Prolonged bed rest is generally not required. Follow the clinic’s advice regarding medication and symptoms that require medical attention.

Depending on the date of IUI or embryo transfer, a blood beta-hCG test is commonly scheduled approximately 9–14 days later.

Light spotting may occur; contact the clinic if there is heavy bleeding, severe pain, fever or shortness of breath.

Costs may be affected by donor type, screening, IUI or IVF, medication, egg collection, ICSI, embryo culture, freezing, storage and travel arrangements.